Skip to main content
AI Market Watch
Loading...

Soombit.ai

Category: AI in Healthcare

Korean generative-AI medical imaging startup whose AIRead-CXR drafts preliminary chest X-ray reports; it is expanding into CT and MRI. Soombit.ai was founded in 2024. The company is led by Bae Woong (배웅). Based in Seoul, South Korea. Team size: 11-50. Total funding raised: $15M. Latest round: Series A. Key investors include SV Investment (lead), Altos Ventures, Kiwoom Investment, iM Investment Partners.

Founded
2024
Headquarters
Seoul, South Korea
Team size
11-50
Total funding
$15M

Value proposition

Generative vision-language AI drafts radiology reports from medical images so radiologists can focus on judgement and revision, easing limited clinical capacity.

Products and solutions

AIRead-CXR (MFDS Class III-approved chest X-ray preliminary report drafting, April 2026, covers 57+ findings in 1-2 seconds), AIRead-CT (brain, chest, abdomen-pelvis CT preliminary reading, targeted for 2027 launch, debuting at RSNA 2026), MR planned next

Unique value

Korea's first MFDS-approved generative AI medical device; it produces full draft reports rather than per-finding detection, using in-house vision-language models.

Target customer

Radiologists and hospitals/healthcare institutions

Industries served

Healthcare / Radiology / Medical imaging

Technology advantage

In-house medical VLMs trained on about 14M chest X-ray image-report pairs; open-source CXR-CLIP research (2023); peer-reviewed clinical validation (Radiology, 2025); regulatory approval first-mover advantage.

How they differentiate

Generative draft-report writing from images (VLM) versus the findings-detection approach of incumbents; first generative AI medical device approval in Korea; team came from Kakao Brain's chest X-ray reading-assistance business.

Main competitors

Lunit, VUNO, Deepnoid (also approved for generative chest X-ray AI)

Key partnerships

INFINITT (integration partner), Taeyoung Soft (integration partner), Techheim (integration partner)

Major milestones

Founded July 2024, GMP certification Oct 2024, Seed Nov 2024, first paper in Radiology Mar 2025, MFDS Class III approval Apr 1 2026 (Korea's first generative AI medical device), Scale-up TIPS selected Sep 2026, Series A Nov 2026, AIRead-CT to debut at RSNA 2026.

Growth metrics

About 11-12 employees; cumulative funding about ₩20B (~$15M) including Scale-up TIPS R&D support; hiring across all functions.

Market positioning

Early leader in generative AI radiology report drafting, moving from CXR into 3D multi-sequence CT/MRI with US FDA and EU CE clearance plans.

Geographic focus

South Korea first; global expansion (US FDA, EU CE) targeted; RSNA 2026 Chicago booth

About Bae Woong (배웅)

Ex-Kakao Brain Chief Healthcare Officer (CHO) and head of healthcare business; ex-VUNO, led medical imaging AI R&D and commercialization; ex-VATECH.

Latest news about Soombit.ai

More AI in Healthcare companies

Official website: